Deficiency of cathepsin S attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice

Cardiovascular Research

Volumn 96, Issue 3, 2012, Pages 401-410

  Qin, Yanwen ^a   Cao, Xu ^a   Guo, Jun ^a   Zhang, Yaozhong ^a   Pan, Lili ^a   Zhang, Hongjia ^a   Li, Huihua ^a   Tang, Chaoshu ^a   Du, Jie ^a   Shi, Guo Ping ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Abdominal aortic aneurysm; Cathepsin S; Extracellular matrix; Inflammation

Indexed keywords

ANGIOTENSIN II; APOLIPOPROTEIN E; CATHEPSIN B; CATHEPSIN K; CATHEPSIN L; CATHEPSIN S; COLLAGEN; ELASTIN; GELATINASE A; GELATINASE B;

ABDOMINAL AORTA; ABDOMINAL AORTA ANEURYSM; ADVENTITIA; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; APOPTOSIS; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME DEFICIENCY; EXTRACELLULAR MATRIX; HISTOPATHOLOGY; INFLAMMATORY CELL; LYMPHOCYTE PROLIFERATION; MICROVASCULATURE; MONOCYTE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; T LYMPHOCYTE; TUNICA MEDIA; WESTERN BLOTTING;

ANGIOTENSIN II; ANIMALS; ANTIGENS, CD3; AORTA, ABDOMINAL; AORTIC ANEURYSM, ABDOMINAL; APOLIPOPROTEINS E; APOPTOSIS; CATHEPSIN K; CATHEPSINS; CELLS, CULTURED; COLLAGEN; DISEASE MODELS, ANIMAL; ELASTIN; INFLAMMATION; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NEOVASCULARIZATION, PATHOLOGIC; T-LYMPHOCYTES; TIME FACTORS;

EID: 84869444979     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvs263     Document Type: Article

References (50)

1. Lederle FA, Johnson GR, Wilson SE, Chute EP, Hye RJ, Makaroun MS et al. The an-eurysm detection and management study screening program: validation cohort and final results. Aneurysm Detection and Management Veterans Affairs Cooperative Study Investigators. Arch Intern Med 2000;160:1425-1430. (Pubitemid 30327444)
2. Nordon IM, Hinchliffe RJ, Loftus IM, Thompson MM. Pathophysiology and epidemiology of abdominal aortic aneurysms. Nat Rev Cardiol 2011;8:92-102.
3. Abdul-Hussien H, Hanemaaijer R, Kleemann R, Verhaaren BF, van Bockel JH, Lindeman JH. The pathophysiology of abdominal aortic aneurysm growth: corresponding and discordant inflammatory and proteolytic processes in abdominal aortic and popliteal artery aneurysms. J Vasc Surg 2010;51:1479-1487.
4. Nordon IM, Hinchliffe RJ, Holt PJ, Loftus IM, Thompson MM. Review of current theories for abdominal aortic aneurysm pathogenesis. Vascular 2009;17:253-263.
5. Daugherty A, Cassis LA. Mechanisms of abdominal aortic aneurysm formation. Curr Atheroscler Rep 2002;4:222-227.
6. Furmaniak-Kazmierczak E, Crawley SW, Carter RL, Maurice DH, Cote GP. Formation of extracellular matrix-digesting invadopodia by primary aortic smooth muscle cells. Circ Res 2007;100:1328-1336. (Pubitemid 46742923)
7. Sukhova GK, Shi GP. Do cathepsins play a role in abdominal aortic aneurysm patho-genesis? Ann N Y Acad Sci 2006;1085:161-169. (Pubitemid 47092000)
8. Qin Y, Shi GP. Cysteinyl cathepsins and mast cell proteases in the pathogenesis and therapeutics of cardiovascular diseases. Pharmacol Ther 2011;131:338-350.
9. Pyo R, Lee JK, Shipley JM, Curci JA, Mao D, Ziporin SJ et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest 2000;105:1641-1649. (Pubitemid 30390315)
10. Lutgens SP, Cleutjens KB, Daemen MJ, Heeneman S. Cathepsin cysteine proteases in cardiovascular disease. FASEB J 2007;21:3029-3041. (Pubitemid 47565524)
11. Sukhova GK, Shi GP, Simon DI, Chapman HA, Libby P. Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest 1998;102:576-583. (Pubitemid 28376160)
12. Shi GP, Dolganov GM. Comprehensive transcriptome of proteases and protease inhibitors in vascular cells. Stroke 2006;37:537-541. (Pubitemid 43732021)
13. Sukhova GK, Zhang Y, Pan JH, Wada Y, Yamamoto T, Naito M et al. Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice. J Clin Invest 2003;111:897-906. (Pubitemid 37074965)
14. Sukhova GK, Wang B, Libby P, Pan JH, Zhang Y, Grubb A et al. Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipoprotein E-null mice. Circ Res 2005;96:368-375. (Pubitemid 40279912)
15. Schulte S, Sun J, Libby P, Macfarlane L, Sun C, Lopez-Ilasaca M et al. Cystatin C deficiency promotes inflammation in angiotensin II-induced abdominal aortic aneurisms in atherosclerotic mice. Am J Pathol 2010;177:456-463.
16. Bai L, Beckers L, Wijnands E, Lutgens SP, Herias MV, Saftig P et al. Cathepsin K gene disruption does not affect murine aneurysm formation. Atherosclerosis 2010;209:96-103.
17. Chapman HA, Riese RJ, Shi GP. Emerging roles for cysteine proteases in human biology. Annu Rev Physiol 1997;59:63-88. (Pubitemid 27142435)
18. Shi GP, Villadangos JA, Dranoff G, Small C, Gu L, Haley KJ et al. Cathepsin S required for normal MHC class II peptide loading and germinal center development. Immunity 1999;10:197-206. (Pubitemid 29115625)
19. Rodgers KJ, Watkins DJ, Miller AL, Chan PY, Karanam S, Brissette WH et al. Destabilizing role of cathepsin S in murine atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2006;26:851-856. (Pubitemid 43732162)
20. de Nooijer R, Bot I, von der Thusen JH, Leeuwenburgh MA, Overkleeft HS, Kraaijeveld AO et al. Leukocyte cathepsin S is a potent regulator of both cell and matrix turnover in advanced atherosclerosis. Arterioscler Thromb Vasc Biol 2009;29:188-194.
21. Shi GP, Sukhova GK, Grubb A, Ducharme A, Rhode LH, Lee RT et al. Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest 1999;104:1191-1197. (Pubitemid 29536290)
22. Lv BJ, Lindholt JS, Cheng X, Wang J, Shi GP. Plasma cathepsin S and cystatin C levels and risk of abdominal aortic aneurysm: a randomized population-based study. PLoS ONE 2012;7:e41813.
23. Daugherty A, Manning MW, Cassis LA. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 2000;105:1605-1612. (Pubitemid 30390311)
24. Sun J, Sukhova GK, Yang M, Wolters PJ, MacFarlane LA, Libby P et al. Mast cells modu late the pathogenesis of elastase-induced abdominal aortic aneurysms in mice. J Clin Invest 2007;117:3359-3368. (Pubitemid 350096992)
25. Fang KC, Raymond WW, Lazarus SC, Caughey GH. Dog mastocytoma cells secrete a; 92-kD gelatinase activated extracellularly by mast cell chymase. J Clin Invest 1996;97: ! 1589-1596. (Pubitemid 26105468)
26. Abraham M, Karni A, Dembinsky A, Miller A, Gandhi R, Anderson D et al. In vitro induction of regulatory T cells by anti-CD3 antibody in humans. J Autoimmun 2008;30:; 21-28.
27. Kosuge H, Haraguchi G, Koga N, Maejima Y, Suzuki J, Isobe M. Pioglitazone prevents ! acute and chronic cardiac allograft rejection. Circulation 2006;113:2613-2622. (Pubitemid 43948010)
28. Kishi M, Yasuda H, Abe Y, Sasaki H, Shimizu M, Arai T et al. Regulatory CD8+ T cells; induced by exposure to all-trans retinoic acid and TGF-beta suppress autoimmune diabetes. Biochem Biophys Res Commun 2010;394:228-232.
29. Mahmoudi M, Siassi F, Mahmoudi MJ, Eshraghian MR, Zarnani AH, Rezaei N et al. Defective T-cell proliferation and IL-2 production in a subgroup of patients with coron-; ary artery disease. Iran J Allergy Asthma Immunol 2010;9:133-140.
30. Sun J, Sukhova GK, Zhang J, Chen H, Sjoberg S, Libby P et al. Cathepsin L activity is ! essential to elastase perfusion-induced abdominal aortic aneurysms in mice. Arterios-cler Thromb Vasc Biol 2011;31:2500-2508.
31. Choke E, Cockerill GW, Dawson J, Wilson RW, Jones A, Loftus IM et al. Increased angiogenesis at the site of abdominal aortic aneurysm rupture. Ann N Y Acad Sci 2006;1085:315-319. (Pubitemid 47091979)
32. Satta J, Soini Y, Mosorin M, Juvonen T. Angiogenesis is associated with mononuclear inflammatory cells in abdominal aortic aneurysms. Ann Chir Gynaecol 1998;87:40-42.
33. Miwa K, Nakashima H, Aoki M, Miyake T, Kawasaki T, Iwai M et al. Inhibition of ets, an ! essential transcription factor for angiogenesis, to prevent the development of abdominal aortic aneurysm in a rat model. Gene Ther 2005;12:1109-1118. (Pubitemid 41030616)
34. Shimizu K, Mitchell RN, Libby P. Inflammation and cellular immune responses in; abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2006;26:987-994. (Pubitemid 43732102)
35. Ailawadi G, Eliason JL, Upchurch GR Jr. Current concepts in the pathogenesis of abdominal aortic aneurysm. J Vasc Surg 2003;38:584-588. (Pubitemid 41123227)
36. Thompson RW, Liao S, Curci JA. Vascular smooth muscle cell apoptosis in abdominal; aortic aneurysms. Coron Artery Dis 1997;8:623-631. (Pubitemid 28029588)
37. Henderson EL, Geng YJ, Sukhova GK, Whittemore AD, Knox J, Libby P. Death of ! smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms. Circulation 1999;99:96-104. (Pubitemid 29035963)
38. Chwieralski CE, Welte T, Buhling F. Cathepsin-regulated apoptosis. Apoptosis 2006;11: | 143-149. (Pubitemid 43291015)
39. Stoka V, Turk V, Turk B. Lysosomal cysteine cathepsins: signaling pathways in apop-tosis. Biol Chem 2007;388:555-560. (Pubitemid 46883446)
40. Ishisaka R, Utsumi T, Kanno T, Arita K, Katunuma N, Akiyama J et al. Participation of a cathepsin L-type protease in the activation of caspase-3. Cell Struct Funct 1999;24:465-470. (Pubitemid 30128954)
41. Zheng T, Kang MJ, Crothers K, Zhu Z, Liu W, Lee CG et al. Role of cathepsin S-dependent epithelial cell apoptosis in IFN-gamma-induced alveolar remodeling and pulmonary emphysema. J Immunol 2005;174:8106-8115. (Pubitemid 40806322)
42. Choke E, Thompson MM, Dawson J, Wilson WR, Sayed S, Loftus IM et al. Abdominal aortic aneurysm rupture is associated with increased medial neovascularization and overexpression of proangiogenic cytokines. Arterioscler Thromb Vasc Biol 2006;26:2077-2082. (Pubitemid 44253791)
43. Premzl A, Turk V, Kos J. Intracellular proteolytic activity of cathepsin B is associated with capillary-like tube formation by endothelial cells in vitro. J Cell Biochem 2006;97:1230-1240.
44. Wang B, Sun J, Kitamoto S, Yang M, Grubb A, Chapman HA et al. Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors. J Biol Chem 2006;281:6020-6029. (Pubitemid 43847703)
45. Shi GP, Sukhova GK, Kuzuya M, Ye Q, Du J, Zhang Y et al. Deficiency of the cysteine protease cathepsin S impairs microvessel growth. Circ Res 2003;92:493-500. (Pubitemid 36368661)
46. Kaneko H, Anzai T, Takahashi T, Kohno T, Shimoda M, Sasaki A et al. Role of vascular endothelial growth factor-A in development of abdominal aortic aneurysm. Cardiovasc Res 2011;91:358-367.
47. Kaneko H, Anzai T, Horiuchi K, Kohno T, Nagai T, Anzai A et al. Tumor necrosis factor-alpha converting enzyme is a key mediator of abdominal aortic aneurysm development. Atherosclerosis 2011;218:470-478.
48. Pradhan-Palikhe P, Vikatmaa P, Lajunen T, Palikhe A, Lepantalo M, Tervahartiala T et al. Elevated MMP-8 and decreased myeloperoxidase concentrations associate significantly with the risk for peripheral atherosclerosis disease and abdominal aortic an-eurysm. Scand J Immunol 2010;72:150-157.
49. Keeling WB, Armstrong PA, Stone PA, Bandyk DF, Shames ML. An overview of matrix metalloproteinases in the pathogenesis and treatment of abdominal aortic aneurysms. Vasc Endovascular Surg 2005;39:457-464. (Pubitemid 41790136)
50. Sun J, Sukhova GK, Zhang J, Chen H, Sjoberg S, Libby P et al. Cathepsin k deficiency reduces elastase perfusion-induced abdominal aortic aneurysms in mice. Arterioscler Thromb Vasc Biol 2012;32:15-23.